Search - tctmd.com

Displaying 21 - 40 of 47

Sort: Relevancy | Date

FDA Says Newer Paclitaxel Data Is ‘Comforting’ but Limited

News Daily News

FDA Says Newer Paclitaxel Data Are ‘Comforting’ but Limited

L.A. McKeown

January 12, 2021

News Features

The Hope Dealers: How Clinicians and New Tech Could End Unnecessary PAD Amputations

L.A. McKeown

December 24, 2020

The finding, from a study with a mean follow-up of 2-and-a-half years, bolsters support for trials and device use to continue.

News Daily News

SWEDEPAD: No Mortality Signal With Paclitaxel in PAD

L.A. McKeown

December 18, 2020

News Conference News VIVA 2020

BVS Reboot? Signs of Durability to 2 Years in Critical Limb-Threatening Ischemia

L.A. McKeown

November 11, 2020

News Conference News TCT 2020

IN.PACT BTK Provides Renewed Hope for Attacking CLI With DCBs

L.A. McKeown

October 18, 2020

News Daily News

Registry Supports Paclitaxel DCBs in CLI Patients to 2 Years

L.A. McKeown

September 17, 2020

News Features

Dire, Unusual STEMI Complications Blamed on COVID-19 Hospital Avoidance

Shelley Wood

April 29, 2020

News Conference News CRT 2020

Newer, Thinner-Strut Abbott Scaffold Prompts Talk of a BVS Comeback

Michael O'Riordan

February 28, 2020

News Daily News

Veterans Study Shows Areas of Need for CLI Care

L.A. McKeown

February 17, 2020

News Conference News LINC 2020

Common-Femoral Lesions: LINC 2020 Experts Hash Out the Best PAD Treatment

L.A. McKeown

January 31, 2020

News Conference News ISET 2020

Leaving the Hospital Nest? OBL Advice From Those Who’ve Done It

Caitlin E. Cox

January 28, 2020

News Conference News ISET 2020

FDA’s First Take on New Paclitaxel Concerns in CLI

Caitlin E. Cox

January 24, 2020

News Conference News ISET 2020

PAD Care on the Backdrop of Cancer Requires Creativity, Persistence

Caitlin E. Cox

January 23, 2020

News Daily News

Paclitaxel DCBs Now Implicated in Death, Amputation in Below-the-Knee CLI

L.A. McKeown

January 15, 2020

News Conference News VIVA 2019

Hope for Bioresorbable Vascular Scaffolds in Peripheral Disease Below the Knee?

L.A. McKeown

November 06, 2019

News Daily News

For Percutaneous LVADs, Vascular Complications Decreasing but Still Common

Caitlin E. Cox

November 06, 2019

News Conference News VIVA 2019

IN.PACT Global Registry Shows Continued Safety, Efficacy at 4 Years for Paclitaxel DCB

L.A. McKeown

November 05, 2019

News Daily News

Bleeding Risk Similar for Peripheral, Coronary Revascularization: EUCLID

Caitlin E. Cox

October 16, 2019

News Daily News

German Analysis Supports Long-term Safety of Paclitaxel-Based Therapies

L.A. McKeown

October 09, 2019

News Conference News TCT 2019

‘Spooky’ Signal Still Haunts Paclitaxel DCBs in PAD, but Updated Analysis Reassures

L.A. McKeown

September 28, 2019

Advertisement

FDA Says Newer Paclitaxel Data Are ‘Comforting’ but Limited

The Hope Dealers: How Clinicians and New Tech Could End Unnecessary PAD Amputations

SWEDEPAD: No Mortality Signal With Paclitaxel in PAD

BVS Reboot? Signs of Durability to 2 Years in Critical Limb-Threatening Ischemia

IN.PACT BTK Provides Renewed Hope for Attacking CLI With DCBs

Registry Supports Paclitaxel DCBs in CLI Patients to 2 Years

Dire, Unusual STEMI Complications Blamed on COVID-19 Hospital Avoidance

Newer, Thinner-Strut Abbott Scaffold Prompts Talk of a BVS Comeback

Veterans Study Shows Areas of Need for CLI Care

Common-Femoral Lesions: LINC 2020 Experts Hash Out the Best PAD Treatment

Leaving the Hospital Nest? OBL Advice From Those Who’ve Done It

FDA’s First Take on New Paclitaxel Concerns in CLI

PAD Care on the Backdrop of Cancer Requires Creativity, Persistence

Paclitaxel DCBs Now Implicated in Death, Amputation in Below-the-Knee CLI

Hope for Bioresorbable Vascular Scaffolds in Peripheral Disease Below the Knee?

For Percutaneous LVADs, Vascular Complications Decreasing but Still Common

IN.PACT Global Registry Shows Continued Safety, Efficacy at 4 Years for Paclitaxel DCB

Bleeding Risk Similar for Peripheral, Coronary Revascularization: EUCLID

German Analysis Supports Long-term Safety of Paclitaxel-Based Therapies

‘Spooky’ Signal Still Haunts Paclitaxel DCBs in PAD, but Updated Analysis Reassures

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content